ARK Genomic Revolution ETF vs TKO Group Holdings Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while TKO Group Holdings Inc trades at $194.36 (market cap $14.24B). The key difference: TKO Group Holdings Inc pays a 1.6% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, TKO Group Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | TKO | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $224.96 |
52-Week Low | $24.02 | $176.49 |
Market Cap | — | $14.24B |
Enterprise Value | — | $18.60B |
Dividend Yield | — | 1.6% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →